Inozyme Pharma, Inc.
SEC Filing List
INZY CIK: 0001693011
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | DONNELLEY FINANCIAL SOLUTIONS /fa | 08/27/2025 | |||
| SCHEDULE 13G/A | SHARTSIS FRIESE LLP /fa | 08/14/2025 | |||
| SCHEDULE 13G/A | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 08/13/2025 | |||
| SCHEDULE 13G/A | SCHULTE ROTH & ZABEL LLP /fa | 08/12/2025 | |||
| SCHEDULE 13G/A | BlackRock Portfolio Management LLC /fa | 07/17/2025 | |||
| 15-12G | Notice of termination of registration of... | Inozyme Pharma, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 07/11/2025 | |
| 4 | Statement of changes in beneficial owner... | Bolte Axel | DONNELLEY FINANCIAL SOLUTIONS /fa | 07/03/2025 | |
| 4 | Statement of changes in beneficial owner... | Sullivan Lynne Marie | DONNELLEY FINANCIAL SOLUTIONS /fa | 07/03/2025 | |
| 4 | Statement of changes in beneficial owner... | Treco Douglas A | DONNELLEY FINANCIAL SOLUTIONS /fa | 07/03/2025 | |
| 4 | Statement of changes in beneficial owner... | Winton Matthew | DONNELLEY FINANCIAL SOLUTIONS /fa | 07/03/2025 | |
| No record found. | |||||
| Load More | |||||
